The first company to apply for IPO under the fifth set of listing standards of the science and technology innovation board has been accepted.

On July 31, the Shanghai Stock Exchange accepted the IPO application of Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd. on the Sci-Tech Innovation Board, becoming the first enterprise to successfully be accepted after the restart of the Sci-Tech Innovation Board's fifth set of listing standards. Tainuo Maibo was established in 2015 and is an innovative biopharmaceutical company. The prospectus shows that the company has received investments from senior professional institutional investors.